|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
64,584,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Co.'s D-Domain powered autologous and allogeneic Chimeric Antigen Receptor T cells (CAR-Ts), including classical single infusion CAR-Ts product candidate, CART-ddBCMA, is for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM), defined as patients with either minimal response or disease progression within 60 days of last treatment. Co. is also developing its ARC-SparX programs, ACLX-001 in r/r MM and ACLX-002 and ACLX-003 in r/r acute myeloid leukemia and myelodysplastic syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
48,456 |
65,191 |
347,858 |
1,874,897 |
| Total Sell Value |
$4,000,116 |
$5,069,878 |
$27,985,813 |
$119,255,895 |
| Total People Sold |
2 |
3 |
4 |
6 |
| Total Sell Transactions |
8 |
12 |
46 |
84 |
| End Date |
2025-07-20 |
2025-04-18 |
2024-10-18 |
2023-10-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gilson Michelle |
CHIEF FINANCIAL OFFICER |
• – – |
2025-10-15 |
4 |
AS |
$91.04 |
$488,315 |
D/D |
(5,364) |
8,466 |
|
- |
|
| Gilson Michelle |
CHIEF FINANCIAL OFFICER |
• – – |
2025-10-06 |
4 |
AS |
$86.22 |
$91,733 |
D/D |
(1,064) |
13,830 |
|
- |
|
| Gilson Michelle |
CHIEF FINANCIAL OFFICER |
• – – |
2025-10-03 |
4 |
AS |
$86.00 |
$419,870 |
D/D |
(4,882) |
14,894 |
|
- |
|
| Heery Christopher |
CHIEF MEDICAL OFFICER |
• – – |
2025-09-30 |
4 |
AS |
$80.55 |
$1,709,723 |
D/D |
(21,034) |
624 |
|
- |
|
| Heery Christopher |
CHIEF MEDICAL OFFICER |
• – – |
2025-09-29 |
4 |
AS |
$80.16 |
$5,852 |
D/D |
(73) |
21,658 |
|
- |
|
| Heery Christopher |
CHIEF MEDICAL OFFICER |
• – – |
2025-09-26 |
4 |
AS |
$80.12 |
$993,155 |
D/D |
(12,396) |
21,731 |
|
- |
|
| Heery Christopher |
CHIEF MEDICAL OFFICER |
• – – |
2025-09-19 |
4 |
AS |
$80.00 |
$24,000 |
D/D |
(300) |
34,127 |
|
- |
|
| Heery Christopher |
CHIEF MEDICAL OFFICER |
• – – |
2025-09-18 |
4 |
AS |
$80.01 |
$267,468 |
D/D |
(3,343) |
34,427 |
|
- |
|
| Elghandour Rami |
SEE REMARKS |
• • – |
2025-08-28 |
4 |
D |
$70.25 |
$38,422,395 |
D/D |
(546,938) |
617,919 |
|
- |
|
| Behbahani Ali |
|
– • – |
2025-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,621 |
2,706 |
|
- |
|
| Behbahani Ali |
|
– • – |
2025-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,586 |
1,925 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-06-10 |
4 |
AS |
$67.36 |
$101,040 |
D/D |
(1,500) |
0 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-06-10 |
4 |
OE |
$6.66 |
$9,990 |
D/D |
1,500 |
1,500 |
|
- |
|
| Gilson Michelle |
CHIEF FINANCIAL OFFICER |
• – – |
2025-05-27 |
4 |
S |
$63.62 |
$784,777 |
D/D |
(12,235) |
19,776 |
|
- |
|
| Gilson Michelle |
CHIEF FINANCIAL OFFICER |
• – – |
2025-05-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,429 |
32,011 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-05-20 |
4 |
AS |
$58.43 |
$87,645 |
D/D |
(1,500) |
0 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-05-20 |
4 |
OE |
$6.66 |
$9,990 |
D/D |
1,500 |
1,500 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-04-29 |
4 |
AS |
$64.20 |
$96,300 |
D/D |
(1,500) |
0 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-04-29 |
4 |
OE |
$6.66 |
$9,990 |
D/D |
1,500 |
1,500 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-04-08 |
4 |
AS |
$57.50 |
$86,250 |
D/D |
(1,500) |
0 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-04-08 |
4 |
OE |
$6.66 |
$9,990 |
D/D |
1,500 |
1,500 |
|
- |
|
| Galligan Andrew H |
|
– • – |
2025-03-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-03-18 |
4 |
AS |
$71.64 |
$107,460 |
D/D |
(1,500) |
0 |
|
- |
|
| Patel Kavita |
|
– • – |
2025-03-18 |
4 |
OE |
$6.66 |
$9,990 |
D/D |
1,500 |
1,500 |
|
- |
|
| Elghandour Rami |
SEE REMARKS |
• • – |
2025-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,015,671 |
1,164,857 |
|
- |
|
213 Records found
|
|
Page 1 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
